Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT) for Treatment of Hematologic Malignancies and Hematopoietic Failure States

NCT00997386 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT00997386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00997386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT) for Treatment of Hematologic Malignancies and Hematopoietic Failure States
Lead sponsor
University of Arizona
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2009
Completion date
January 31, 2016
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, aplastic, hematologic neoplasms, hemoglobinuria, paroxysmal, multiple myeloma, myelofibrosis